INTERNATIONAL PATENT: PAMPLONA THERAPEUTICS (SHENZHEN) CO., LTD., 潘普洛纳生物科技（深圳）有限公司, GUANGZHOU IMD PHARMACEUTICAL CO., LTD., 广州智药生物科技有限公司 FILES APPLICATION FOR "COMPOUND TARGETING IRAK PROTEIN INHIBITION OR DEGRADATION AND USE THEREOF"

Posted On: 2025-02-24

GENEVA, Feb. 24 -- PAMPLONA THERAPEUTICS (SHENZHEN) CO., LTD. (8th Floor, Unit B, Building 1, Phase II, Weiguang Life Science Park, 669 Beizhen Road, Yungu Community, Xinhu Street, Guangming District,Shenzhen, Guangdong 518107), 潘普洛纳生物科技（深圳）有限公司 (中国广东省深圳市光明区新湖街道云谷社区北圳路669号卫光生命科学园二期1栋B单元8层 ), GUANGZHOU IMD PHARMACEUTICAL CO., LTD. (193 Shuixi Road, Apt.1613, Huangpu DistrictGuangzhou,...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: PAMPLONA THERAPEUTICS (SHENZHEN) CO., LTD., 潘普洛纳生物科技（深圳）有限公司, GUANGZHOU IMD PHARMACEUTICAL CO., LTD., 广州智药生物科技有限公司 FILES APPLICATION FOR "COMPOUND TARGETING IRAK PROTEIN INHIBITION OR DEGRADATION AND USE THEREOF"